BeOne Medicines Ltd. American Depositary Shares Earnings Dividend

BeOne Medicines Ltd. American Depositary Shares’s revenue jumped 29.63% since last year same period to $1705.07Mn in the Q2 2026. On a quarterly growth basis, BeOne Medicines Ltd. American Depositary Shares has generated 12.66% jump in its revenue since last 3-months.

BeOne Medicines Ltd. American Depositary Shares’s net profit jumped 151.28% since last year same period to $237.01Mn in the Q2 2026. On a quarterly growth basis, BeOne Medicines Ltd. American Depositary Shares has generated 4.24% jump in its net profits since last 3-months.

BeOne Medicines Ltd. American Depositary Shares’s net profit margin jumped 93.84% since last year same period to 13.9% in the Q2 2026. On a quarterly growth basis, BeOne Medicines Ltd. American Depositary Shares has generated -7.47% fall in its net profit margins since last 3-months.

BeOne Medicines Ltd. American Depositary Shares’s earning per share (EPS) estimates for the current quarter stand at 2.42 - a 72.86% jump from last quarter’s estimates.

BeOne Medicines Ltd. American Depositary Shares’s earning per share (EPS) estimates for the current year stand at 2.42.

BeOne Medicines Ltd. American Depositary Shares’s earning per share (EPS) jumped 144.05% since last year same period to 2.05 in the Q2 2026. This indicates that the BeOne Medicines Ltd. American Depositary Shares has generated 144.05% annual rate of jump in its earning per share (EPS) in the last 4 quarters.